(en) Managing biochemical recurrence (BCR) of localized prostate cancers (PCa) that have failed all options for local treatment has been the topic of an incommensurable number of manuscripts and opinion papers. [...]
Achard, V., & Tombal, B. (2024). High-risk biochemical recurrence of locally treated prostate cancer after EMBARK. An end to decades of conventional wisdom? Prostate Cancer and Prostatic Diseases, 27(4), 665-666. https://doi.org/10.1038/s41391-023-00767-y (Original work published 2024)